Myriad Genetics, Inc.
Biopharmaceutical company reports fourth quarter financial results
Published in Pharma Investments, Ventures and Law Weekly, September 19th, 2004
Predictive medicine revenues for the year ended June 30, 2004, increased to a record $43.3 million from $34.7 million for fiscal 2003, an increase of 25%. Fourth quarter predictive medicine revenues were up 40% over the fourth quarter of fiscal 2003 to $13.1 million, from $9.4 million.
This increase was due primarily to growth in the company's lead predictive medicine product, BRACAnalysis, for breast and ovarian cancer and its COLARIS family of products for colorectal cancer.
The gross profit margin on predictive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Access Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $0.17 per share - Akorn, Inc.
Pharmaceutical firm reports 25% increase in revenues - Albany Molecular Research, Inc.
Drug discovery firm reports 22.2% decrease in revenues - Alkermes, Inc.
Pharmaceutical firm reports loss of $0.40 per share - America Oriental Bioengineering
Chinese biotech firm reports 23% revenue increase - Anadys Pharmaceuticals, Inc.
Hepatitis drug maker reports loss of $0.50 per share - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
